EUVIMEDEUVIMED entdecken
Crossref

Ophthalmic Manifestations of Multiple Sclerosis: A Case Series

Nafeeseh Montazerin, Zhale Rajavi, H Ziaei Ardakani, Azadeh Haseli-Mofrad

Journal of Ophthalmic and Optometric Sciences · 19.05.2025

DOI: 10.22037/joos.v8i3.48095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 19.05.2025. Verfasst von Nafeeseh Montazerin und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This case series study reports the ophthalmic manifestations observed in multiple sclerosis (MS) patients and their diagnostic implications.Patients and Methods: A cross-sectional case series included 15 MS patients from Negah Eye Hospital, Tehran, Iran. Each patient underwent a comprehensive ophthalmic evaluation, including best-corrected visual acuity (BCVA), pupillary response, ocular motility, slit-lamp biomicroscopy, fundoscopy, visual field testing, optical coherence tomography (OCT), and visual evoked potentials (VEP). Patient demographics, systemic conditions, and treatment history were also analyzed.

Results

Our study included 15 patients with MS (11 females, 4 males, aged 18–56 years). BCVA ranged from 20/20 to 20/100, with objective color vision impairment in 6 % of cases. Relative afferent pupillary defect was observed in 6 % of patients. Optic neuritis and visual disturbances were common findings. Optic nerve atrophy was observed in 20 % of patients. Ocular motility disturbances, including internuclear ophthalmoplegia and diplopia, were present in 20 %. Visual field abnormalities were detected in 26 %, while VEP testing showed delayed latency in all tested eyes. OCT results were normal in 20 % of cases. Uveitis was noted in 6 %, and 13 % had concurrent COVID-19 infection.

Conclusion

This case series highlights the diverse ophthalmic manifestations of MS, with optic neuritis and ocular motility disturbances as key findings. VEP and OCT provide valuable diagnostic insights, especially for subclinical cases. A comprehensive ophthalmic assessment is crucial in MS management to improve diagnosis and prevent unnecessary treatments.

Schlagwörter

multiple sclerosisocular manifestationsoptic neuritisoptic atrophyinternuclear ophthalmoplegiadiplopiavisual field defectsrelative afferent pupillary defectcolor vision deficiencyuveitis

Zitieren

APA

Montazerin, N., Rajavi, Z., Ardakani, H. Z., & Haseli-Mofrad, A. (2025). Ophthalmic Manifestations of Multiple Sclerosis: A Case Series. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v8i3.48095

Vancouver

Montazerin N, Rajavi Z, Ardakani HZ, Haseli-Mofrad A. Ophthalmic Manifestations of Multiple Sclerosis: A Case Series. Journal of Ophthalmic and Optometric Sciences. 2025. doi:10.22037/joos.v8i3.48095

BibTeX
@article{Montazerin2025,
  author = {Montazerin, Nafeeseh and Rajavi, Zhale and Ardakani, H Ziaei and Haseli-Mofrad, Azadeh},
  title = {Ophthalmic Manifestations of Multiple Sclerosis: A Case Series},
  journal = {Journal of Ophthalmic and Optometric Sciences},
  year = {2025},
  doi = {10.22037/joos.v8i3.48095}
}
Kostenlos starten →